Ipsen quarterly sales drop 0.3 pct, hurt by Europe
PARIS Jan 30 (Reuters) - French drugmaker Ipsen on Wednesday said fourth-quarter sales fell 0.3 percent as a drop in demand for drugs sold via primary care facilities outweighed growth in drugs prescribed by specialist doctors.
Revenue fell to 294.9 million euros ($397.5 million) in the October-December period from 295.8 million a year earlier, Ipsen said in a statement. ($1 = 0.7420 euros) (Reporting By Christian Plumb)
- U.S. Mega Millions lottery up to $400 million, 2nd-biggest ever
- Pope Francis named Time's Person of the Year |
- Uruguay becomes first country to legalize marijuana trade
- Thousands of South Africans line up to see Mandela lie in state |
- China bitcoin arbitrage ends as traders work around capital controls